SYN **BOUGHT**@$2.989 - Pertussis update might kick in. In addition - Synthetic Biologics to Report Year End 2013 Financial Results - Company Focused on Novel Anti-Infective Pipeline for the Prevention and Treatment of Serious Infections and Other Diseases - - Conference Call Scheduled for Monday, March 31, 2014, at 10:00 am EDT -